Evidence map›Paper›PMID 21686228›Full record

ArticleTransactions of the American Clinical and Climatological Association2011

H1 and PAR2 receptors enhance delivery of immune-competent cells and molecules by interrupting E-cadherin adhesion in epithelia.

D Michael Shasby, Michael C Winter

Open access · greenAbstract read
In one paragraph

Article in Transactions of the American Clinical and Climatological Association, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

D Michael ShasbyDepartment of Internal Medicine, University of Iowa Carver College of Medicine, Newton Rd., Iowa City, IA 52242, USA. michael-shasby@uiowa.edu
Michael C Winter
University of Iowa · US

Funding

REVERSIBLE OXIDANT INJURY TO EPITHELIUMR01HL033540 · NHLBI · UNIVERSITY OF IOWA · PI SHASBY, DOUGLAS MICHAEL · 1985 to 2005
$1.3M
NHLBI NIH HHS HL33540NHLBI NIH HHS R01 HL033540
6 · The paper itself

Abstract

The lung's epithelial surface is at the same time vitally exchanging gas with the environment and acting as a barrier that protects the organism from the environment. We hypothesized that activation of epithelial-cell G-protein-coupled receptors for immune-defense molecules would temporarily interrupt cadherin-dependent cell-cell adhesion of epithelial cells and thereby focally and temporarily compromise the epithelial barrier to facilitate delivery of other immune molecules and cells to challenged sites. Activation of type 1 histamine or type 2 PAR receptors on the basolateral surface of primary airway epithelial cells or L-cells expressing E-cadherin interrupted cadherin adhesion and caused approximately a 50% decrease in the epithelial barrier for 2-3 minutes. Given basic biochemical observations of others, we further hypothesized that activation of the receptors altered the barrier by phosphorylating tyrosines on an essential cadherin-complex component, beta-catenin. Y-F mutations in beta-catenin completely blocked the effects of activating the same receptors on cadherin-dependent adhesion and on the epithelial barrier. Hence, G-protein-coupled receptors responding to immune-defense molecules temporarily and focally interrupt the lung epithelial barrier by compromising cadherin-based adhesion.

Indexed as

Cell AdhesionImmunity, MucosalSignal TransductionAnimalsAntigens, CDbeta CateninCadherinsCell LineDogsElectric ImpedanceEpithelial CellsHumansKidneyMutationOligopeptidesPermeabilityAntigens, CDbeta CateninCadherinsCDH1 protein, humanCTNNB1 protein, humanOligopeptidesReceptor, PAR-2Receptors, Histamine H1seryl-leucyl-isoleucyl-glycyl-arginyl-leucineTyrosine

Identifiers

PMID21686228
PMCPMC3116348
OpenAlexW1506072071

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.